Page last updated: 2024-11-12

LSM-1328

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID10040286
CHEMBL ID602850
CHEBI ID91540

Synonyms (17)

Synonym
HMS3269L15
BRD-A13964793-001-01-8
NCGC00167824-01
CHEMBL602850 ,
4-(3''-fluorophenethyl)-4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecan-3-ol
bdbm50305342
tc 1
(n-(3'-fluorophenyl)ethyl-4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecan-3-ol
362512-81-0
AKOS024457232
CHEBI:91540
Q27163373
lsm-1328
HMS3677P15
HMS3413P15
5-[2-(3-fluorophenyl)ethyl]-5-azahexacyclo[5.4.1.0?,?.0?,??.0?,?.0?,??]dodecan-4-ol
5-[2-(3-fluorophenyl)ethyl]-5-azahexacyclo[5.4.1.02,6.03,10.04,8.09,12]dodecan-4-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sesquiterpenoidAny terpenoid derived from a sesquiterpene. The term includes compounds in which the C15 skeleton of the parent sesquiterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alpha-2C adrenergic receptorHomo sapiens (human)Ki10.00000.00030.483410.0000AID452471
Sodium-dependent dopamine transporter Homo sapiens (human)Ki10.00000.00021.11158.0280AID452469
Sigma non-opioid intracellular receptor 1Cavia porcellus (domestic guinea pig)Ki5.00500.00000.338510.0000AID730796
Sigma non-opioid intracellular receptor 1Homo sapiens (human)Ki0.01200.00000.490110.0000AID452467
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (45)

Processvia Protein(s)Taxonomy
regulation of smooth muscle contractionAlpha-2C adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-2C adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-2C adrenergic receptorHomo sapiens (human)
negative regulation of norepinephrine secretionAlpha-2C adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-2C adrenergic receptorHomo sapiens (human)
platelet activationAlpha-2C adrenergic receptorHomo sapiens (human)
activation of protein kinase B activityAlpha-2C adrenergic receptorHomo sapiens (human)
negative regulation of epinephrine secretionAlpha-2C adrenergic receptorHomo sapiens (human)
receptor transactivationAlpha-2C adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-2C adrenergic receptorHomo sapiens (human)
positive regulation of neuron differentiationAlpha-2C adrenergic receptorHomo sapiens (human)
adrenergic receptor signaling pathwayAlpha-2C adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-2C adrenergic receptorHomo sapiens (human)
negative regulation of insulin secretionAlpha-2C adrenergic receptorHomo sapiens (human)
monoamine transportSodium-dependent dopamine transporter Homo sapiens (human)
neurotransmitter transportSodium-dependent dopamine transporter Homo sapiens (human)
lactationSodium-dependent dopamine transporter Homo sapiens (human)
sensory perception of smellSodium-dependent dopamine transporter Homo sapiens (human)
locomotory behaviorSodium-dependent dopamine transporter Homo sapiens (human)
response to xenobiotic stimulusSodium-dependent dopamine transporter Homo sapiens (human)
response to iron ionSodium-dependent dopamine transporter Homo sapiens (human)
dopamine transportSodium-dependent dopamine transporter Homo sapiens (human)
adenohypophysis developmentSodium-dependent dopamine transporter Homo sapiens (human)
response to nicotineSodium-dependent dopamine transporter Homo sapiens (human)
positive regulation of multicellular organism growthSodium-dependent dopamine transporter Homo sapiens (human)
regulation of dopamine metabolic processSodium-dependent dopamine transporter Homo sapiens (human)
response to cocaineSodium-dependent dopamine transporter Homo sapiens (human)
dopamine biosynthetic processSodium-dependent dopamine transporter Homo sapiens (human)
dopamine catabolic processSodium-dependent dopamine transporter Homo sapiens (human)
response to ethanolSodium-dependent dopamine transporter Homo sapiens (human)
cognitionSodium-dependent dopamine transporter Homo sapiens (human)
dopamine uptake involved in synaptic transmissionSodium-dependent dopamine transporter Homo sapiens (human)
response to cAMPSodium-dependent dopamine transporter Homo sapiens (human)
norepinephrine uptakeSodium-dependent dopamine transporter Homo sapiens (human)
prepulse inhibitionSodium-dependent dopamine transporter Homo sapiens (human)
dopamine uptakeSodium-dependent dopamine transporter Homo sapiens (human)
hyaloid vascular plexus regressionSodium-dependent dopamine transporter Homo sapiens (human)
amino acid transportSodium-dependent dopamine transporter Homo sapiens (human)
norepinephrine transportSodium-dependent dopamine transporter Homo sapiens (human)
sodium ion transmembrane transportSodium-dependent dopamine transporter Homo sapiens (human)
lipid transportSigma non-opioid intracellular receptor 1Homo sapiens (human)
nervous system developmentSigma non-opioid intracellular receptor 1Homo sapiens (human)
G protein-coupled opioid receptor signaling pathwaySigma non-opioid intracellular receptor 1Homo sapiens (human)
regulation of neuron apoptotic processSigma non-opioid intracellular receptor 1Homo sapiens (human)
protein homotrimerizationSigma non-opioid intracellular receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (20)

Processvia Protein(s)Taxonomy
alpha2-adrenergic receptor activityAlpha-2C adrenergic receptorHomo sapiens (human)
protein bindingAlpha-2C adrenergic receptorHomo sapiens (human)
alpha-2A adrenergic receptor bindingAlpha-2C adrenergic receptorHomo sapiens (human)
protein homodimerization activityAlpha-2C adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-2C adrenergic receptorHomo sapiens (human)
epinephrine bindingAlpha-2C adrenergic receptorHomo sapiens (human)
guanyl-nucleotide exchange factor activityAlpha-2C adrenergic receptorHomo sapiens (human)
protease bindingSodium-dependent dopamine transporter Homo sapiens (human)
signaling receptor bindingSodium-dependent dopamine transporter Homo sapiens (human)
neurotransmitter transmembrane transporter activitySodium-dependent dopamine transporter Homo sapiens (human)
dopamine:sodium symporter activitySodium-dependent dopamine transporter Homo sapiens (human)
protein bindingSodium-dependent dopamine transporter Homo sapiens (human)
monoamine transmembrane transporter activitySodium-dependent dopamine transporter Homo sapiens (human)
dopamine bindingSodium-dependent dopamine transporter Homo sapiens (human)
amine bindingSodium-dependent dopamine transporter Homo sapiens (human)
protein-containing complex bindingSodium-dependent dopamine transporter Homo sapiens (human)
metal ion bindingSodium-dependent dopamine transporter Homo sapiens (human)
protein phosphatase 2A bindingSodium-dependent dopamine transporter Homo sapiens (human)
heterocyclic compound bindingSodium-dependent dopamine transporter Homo sapiens (human)
norepinephrine:sodium symporter activitySodium-dependent dopamine transporter Homo sapiens (human)
G protein-coupled opioid receptor activitySigma non-opioid intracellular receptor 1Homo sapiens (human)
protein bindingSigma non-opioid intracellular receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
cytoplasmAlpha-2C adrenergic receptorHomo sapiens (human)
endosomeAlpha-2C adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2C adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2C adrenergic receptorHomo sapiens (human)
cytoplasmSodium-dependent dopamine transporter Homo sapiens (human)
plasma membraneSodium-dependent dopamine transporter Homo sapiens (human)
cell surfaceSodium-dependent dopamine transporter Homo sapiens (human)
membraneSodium-dependent dopamine transporter Homo sapiens (human)
axonSodium-dependent dopamine transporter Homo sapiens (human)
neuron projectionSodium-dependent dopamine transporter Homo sapiens (human)
neuronal cell bodySodium-dependent dopamine transporter Homo sapiens (human)
axon terminusSodium-dependent dopamine transporter Homo sapiens (human)
membrane raftSodium-dependent dopamine transporter Homo sapiens (human)
postsynaptic membraneSodium-dependent dopamine transporter Homo sapiens (human)
dopaminergic synapseSodium-dependent dopamine transporter Homo sapiens (human)
flotillin complexSodium-dependent dopamine transporter Homo sapiens (human)
axonSodium-dependent dopamine transporter Homo sapiens (human)
presynaptic membraneSodium-dependent dopamine transporter Homo sapiens (human)
plasma membraneSodium-dependent dopamine transporter Homo sapiens (human)
neuronal cell body membraneSodium-dependent dopamine transporter Homo sapiens (human)
nuclear envelopeSigma non-opioid intracellular receptor 1Homo sapiens (human)
nuclear inner membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
nuclear outer membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
endoplasmic reticulumSigma non-opioid intracellular receptor 1Homo sapiens (human)
endoplasmic reticulum membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
lipid dropletSigma non-opioid intracellular receptor 1Homo sapiens (human)
cytosolSigma non-opioid intracellular receptor 1Homo sapiens (human)
postsynaptic densitySigma non-opioid intracellular receptor 1Homo sapiens (human)
membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
growth coneSigma non-opioid intracellular receptor 1Homo sapiens (human)
cytoplasmic vesicleSigma non-opioid intracellular receptor 1Homo sapiens (human)
anchoring junctionSigma non-opioid intracellular receptor 1Homo sapiens (human)
postsynaptic density membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
endoplasmic reticulumSigma non-opioid intracellular receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (108)

Assay IDTitleYearJournalArticle
AID772814Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID716351Binding affinity to M4 muscarinic receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772775Inhibition of muscarinic M1 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452498Inhibition of D2 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772777Inhibition of 5-HT5A receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID716581Binding affinity to Histamine H3 receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID716578Binding affinity to D5 dopamine receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID452468Binding affinity to sigma 2 receptor2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772783Inhibition of histamine H4 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452493Inhibition of beta2 adrenoceptor receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452485Inhibition of 5HT receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452500Inhibition of Delta opioid receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716330Binding affinity to 5-HT1B receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID716577Binding affinity to D4 dopamine receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID452474Inhibition of 5HT1B receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716350Binding affinity to M3 muscarinic receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID452482Inhibition of 5HT5A receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452480Inhibition of 5HT3 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452502Inhibition of histamine H2 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452506Inhibition of mu opioid receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772778Inhibition of 5-HT6 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452504Inhibition of histamine H4 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716339Binding affinity to kappa opioid receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID716349Binding affinity to M2 muscarinic receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID452487Inhibition of Alpha1B adrenoceptor receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452483Inhibition of 5HT6 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716354Binding affinity to M5 muscarinic receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772791Inhibition of rat brain BZP receptor by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID716576Binding affinity to D2 dopamine receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID716580Binding affinity to Histamine H1 receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID716337Binding affinity to mu opioid receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID452490Inhibition of Alpha2C adrenoceptor receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716575Binding affinity to D1 dopamine receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772771Inhibition of muscarinic M4 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452489Inhibition of Alpha2B adrenoceptor receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452471Binding affinity to Alpha2C adrenoceptor receptor2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452475Inhibition of 5HT1D receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID730796Displacement of [3H](+)-pentazocine from sigma-1 receptor in guinea pig brain2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
3D-QSAR and docking studies of pentacycloundecylamines at the sigma-1 (σ1) receptor.
AID452503Inhibition of histamine H3 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772769Inhibition of kappa opioid receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452481Inhibition of 5HT4 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772772Inhibition of muscarinic M5 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452479Inhibition of 5HT2C receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772790Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452477Inhibition of 5HT2A receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452492Inhibition of beta-1 adrenoceptor receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452507Inhibition of NET at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716345Binding affinity to 5-HT7 receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID716569Binding affinity to D3 dopamine receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772796Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID716346Binding affinity to M1 muscarinic receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID716582Binding affinity to 5-HT2B receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772803Neuroprotective activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated nitric oxide release up to 100 uM after 20 to 24 hrs by Griess assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID716327Binding affinity to Histamine H2 receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID452469Binding affinity to DAT2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452486Inhibition of Alpha1A adrenoceptor receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716589Binding affinity to alpha2A adrenergic receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772780Inhibition of 5-HT2A receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID772813Displacement of [3H]-citalopram from human SERT expressed in HEK cell membranes2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452495Inhibition of CB1 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772789Inhibition of dopamine D3 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452497Inhibition of D1 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772788Inhibition of dopamine D4 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID772795Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID716312Binding affinity to alpha1B adrenergic receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772768Inhibition of mu opioid receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452496Inhibition of CB2 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772784Inhibition of histamine H3 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID772779Inhibition of 5-HT2B receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID772794Inhibition of adrenergic alpha2C receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452499Inhibition of DAT at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452470Selectivity, ratio of Ki for sigma 1 to Ki for sigma 22010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772781Inhibition of 5-HT1B receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID716311Binding affinity to alpha1A adrenergic2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID716584Binding affinity to 5-HT5A receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID452467Binding affinity to sigma 1 receptor2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716355Binding affinity to NET2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772815Displacement of [3H]-WIN-35,428 from human DAT expressed in HEK cell membranes2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID716333Binding affinity to 5-HT2A receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772787Inhibition of dopamine D5 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID772774Inhibition of muscarinic M2 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452476Inhibition of 5HT1E receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772776Inhibition of 5-HT7 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID716586Binding affinity to delta opioid receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772782Inhibition of 5-HT1A receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID772792Inhibition of Ca2+ channel (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452484Inhibition of 5HT7 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452505Inhibition of Kappa opioid receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772785Inhibition of histamine H2 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452472Inhibition of 5HT1A receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716585Binding affinity to 5-HT6 receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID772770Inhibition of delta opioid receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452494Inhibition of Ca2+ channel at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716583Binding affinity to 5-HT2C receptor2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID452509Inhibition of phencyclidine binding site of NMDA receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID452501Inhibition of histamine H1 receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772797Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID772786Inhibition of histamine H1 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID772793Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID452478Inhibition of 5HT2B receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID716344Binding affinity to SERT2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
AID452488Inhibition of Alpha2A adrenoceptor receptor at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
AID772773Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1508628Confirmatory qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1508629Cell Viability qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1508627Counterscreen qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: GLuc-NoTag assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]